This review aims to provide an overview of the potential use of NSAIDs and selective COX-2 inhibitors in the treatment of breast cancer, namely pre-clinical in vitro and in vivo studies used in the treatment of breast cancer. This evidence concerns the gene PTGS2 and breast cancer.